The global smart insulin pens and pumps market size is expected to reach USD 6.3 billion by 2026, registering around 10.0% CAGR over the forecast period according to a new report by Grand View Research, Inc. Major market drivers include continuous technological advancements in the field of diabetes care along with growing adoption of advanced diabetes management methods. The rising geriatric population coupled with the increasing incidence of diabetes as lifestyle associated disease are the factors expected to drive the product demand. Self-injection devices with integrated connectivity have become an important element of the digital ecosystem.
Smart insulin pens and pumps have created new standards for diabetes care. With the advent of Artificial Intelligence (AI), the entire paradigm of diabetes management has been transformed from simple Bluetooth enabled insulin delivery devices to an artificial pancreas. Furthermore, increasing investment and rising number of new product launches are expected to widen growth opportunities. For Instance, in July 2017, Cellnovo a French medtech company announced to raise USD 19.27 million to improve its product and to continue the R&D in artificial pancreas system. Many key players are focusing on technological collaborations, which is expected to have a long-term positive impact on the market. For instance, in September 2019, Medtronic collaborated with Novo Nordisk to integrate Novo future smart insulin pen dosage data with Medtronic CGM devices.
To Know More About Smart Insulin Pens And Pumps Market, Access Sample Report @ https://www.grandviewresearch.com/industry-analysis/smart-insulin-pens-pumps-market/request/rs1
Further key findings from the report suggest:
- North America dominated the market in 2018 owing to favorable reimbursement policies, presence of key players, and high adoption rates for advanced technologies
- By insulin pump types, Medtronic’s MiniMed accounted for the largest market share in 2018 and is expected maintain its dominance over the forecast period
- Companion medical Inpen is expected to register the fastest CAGR over the forecast period, owing to high adoption rate and advanced features
- By end use, hospital segment held the largest share of the smart insulin pens and pumps market in 2018. Homecare segment, on the other hand, is expected to register the fastest CAGR during the forecast period
- The leading players present in the market are Companion Medical Inc.; Novo Nordisk; Emperra Gmbh E-Health technologies; Jiangasu Delfu medical device Co Ltd; Insulet Corporation;Cellenovo; Medronic Inc.; F Hoffmann-La Roche; Ypsomed; Tandem Diabetes Care; Sooil Development; Valeritas Inc.; and others. Major players are focusing on technological collaboration and product launches
Browse Details of Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/smart-insulin-pens-pumps-market
Grand View Research has segmented the global smart insulin pens and pumps market on the basis of product type, product, end use, and region:
Smart Insulin Pens and Pumps Product Type Outlook (Revenue, USD Million, 2015 – 2026)
- Smart Insulin Pens
- Companion Medical (Inpen)
- Novo Nordisk (Novo6 and Novo Echo)
- Emperra Gmbh (ESYSTA Pen)
- Pendiq intelligent diabetes care (Pendiq 2.0)
- Others
- Smart Insulin Pumps
- Minimed (630G and 670G,)
- Accuchek (Combo and Insight)
- Tandem (T:slim X2, and G4)
- Omnipod
- My Life Omnipod
- Others
Smart Insulin Pens and Pumps End-use Outlook (Revenue, USD Million, 2015 – 2026)
- Hospitals and Clinics
- Homecare
- Laboratories
Smart Insulin Pens and Pumps Regional Outlook (Revenue, USD Million, 2015 – 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Key Topics Covered
Table of Content
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End-use
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Procedure outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
…. continue
Browse Related Reports :
Digital Diabetes Management Market By Product (Smart Glucose Meter, CBGM, Smart Insulin Pen, Smart Insulin Pump), By App, By Type, And Segment Forecasts, 2019 – 2026:
https://www.grandviewresearch.com/industry-analysis/digital-diabetes-management-market
Insulin Delivery Devices Market By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare, Assisted Living Centers, & Nursing Homes), And Segment Forecasts, 2018 – 2025:
https://www.grandviewresearch.com/industry-analysis/insulin-delivery-devices-market
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/smart-insulin-pens-pumps-market